Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma
Eurasian Journal of Medicine and Oncology · 16.11.2026 · 026300370
DOI: 10.36922/ejmo026300370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 16.11.2026. Verfasst von Xuehong He und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Minimal extrathyroidal extension (mETE) is an adverse feature of papillary thyroid microcarcinoma (PTMC), but its preoperative identification remains challenging.
Objective
To develop and validate a dual-phase contrast-enhanced computed tomography (CT) radiomics model and evaluate the complementary value of clinical factors for predicting mETE in PTMC.
Methods
This retrospective study included 311 patients with pathologically confirmed PTMC, randomly assigned to training (n = 217) and testing (n = 94) cohorts. Radiomics features were extracted from arterial- and venous-phase contrast-enhanced CT images and reduced using correlation analysis and least absolute shrinkage and selection operator logistic regression. Independent clinical and conventional imaging predictors were identified by multivariable logistic regression. Clinical, radiomics, and combined models were evaluated by receiver operating characteristic curve analysis, calibration, decision curve analysis, net reclassification improvement, and integrated discrimination improvement.
Results
Thirty-eight radiomics features were retained. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and ultrasonographic capsular contact status were independent predictors of mETE. In the training cohort, the clinical, radiomics, and combined models achieved areas under the curve (AUCs) of 0.765, 0.916, and 0.923, respectively; corresponding AUCs in the testing cohort were 0.615, 0.822, and 0.825. Both the radiomics and combined models demonstrated significantly better discrimination than the clinical model, whereas their difference was not statistically significant (p = 0.894).
Conclusion
The dual-phase CT radiomics model showed good discrimination for mETE in PTMC. Clinical factors provided complementary information but did not significantly improve discrimination. The radiomics-based model may serve as an auxiliary tool for preoperative risk assessment. However, prospective multicenter studies and independent external validation are warranted to establish its clinical utility.
Zitieren
APA
He, X., Zhou, B., Lv, L., Ma, J., Zou, Y., Huang, J., & Song, Z. (2026). Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma. Eurasian Journal of Medicine and Oncology, 0(0), 026300370. https://doi.org/10.36922/ejmo026300370
Vancouver
He X, Zhou B, Lv L, Ma J, Zou Y, Huang J, et al. Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma. Eurasian Journal of Medicine and Oncology. 2026;0(0):026300370. doi:10.36922/ejmo026300370
BibTeX
@article{He2026,
author = {He, Xuehong and Zhou, Bo and Lv, Liang and Ma, Jiang and Zou, Ya and Huang, Jie and Song, Zuhua},
title = {Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {026300370},
doi = {10.36922/ejmo026300370}
}
EUVIMED